Lisanti Capital Growth, LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2023$2,894,791
-56.2%
34,470
-60.5%
0.40%
-56.5%
Q1 2023$6,602,899
+3.7%
87,190
-15.5%
0.92%
+5.9%
Q4 2022$6,368,578
+47.9%
103,1850.0%0.87%
+51.0%
Q3 2022$4,307,000
+29.5%
103,185
-2.5%
0.58%
+27.4%
Q2 2022$3,327,000
+213.0%
105,780
+188.4%
0.45%
+30.6%
Q2 2019$1,063,00036,6800.35%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders